The Complement System: Your Blood’s Silent Army
Long before an antibody or a white cell shows up, your blood is already armed. About 30 complement proteins drift in your plasma doing nothing — until a germ trips one. Then, in seconds, they cascade: three separate triggers all converge on a single switch, the C3 convertase, which splits C3 into a tag that coats the microbe (“eat me”) and a signal that calls in inflammation. Keep it rolling and the proteins build a membrane attack complex that drills a pore and bursts the bug open. Press play and watch a silent army come to life.
Try this: start on Bacterium arrives and watch the MAC punch a hole. Then switch to Self cell — the same attack bounces off CD55/CD59. Now flip on PNH: regulators lost and watch complement turn on your own red cell.
Live complement readout
What’s happening
Real vs. illustrative: the serum-C3 reference band (90–180 mg/dL) and the protein names (C3, C5, MAC/C5b-9, CD55, CD59, MBL, eculizumab) are real. The exact counts, the speed of the cascade, and the rate the C3 value moves are a simplified model to make the mechanism visible — in life the whole thing fires far faster and involves dozens more proteins than shown.
The Science in Plain Language
Your blood was armed before you were born
We tend to think of immunity as white blood cells and antibodies — the parts that learn. But your plasma also carries a fixed, hard-wired defense that needs no training and no memory: the complement system, about 30 proteins (plus their regulators) made mostly by your liver and circulating at all times. They are named with a C and a number — C1 through C9 — in the order they were discovered, not the order they act (which is part of why the topic feels confusing). At rest they do nothing. The instant a pathogen’s surface trips one of them, they cascade: each activated protein cuts and activates the next, amplifying a tiny spark into an overwhelming response in seconds.
Three doors, one hallway: the pathways converge
There are three ways to start the cascade, and the animation shows all three feeding into one point. The classical pathway starts when an antibody latches onto a microbe and the protein C1q recognizes that bound antibody. The lectin pathway starts when a plasma protein called mannose-binding lectin (MBL) grabs the specific sugars (like mannose) that stud bacterial and fungal surfaces but not ours. The alternative pathway needs no trigger at all: a small fraction of C3 spontaneously activates every moment — the famous “tick-over” — and sticks to any surface that isn’t actively protected as “self.” Three doors, but they all open into the same hallway: the C3 convertase.
C3: the hinge the whole system turns on
C3 is the most abundant complement protein in your blood — the reason a C3 blood test exists and a low value matters. The C3 convertase does one job: it splits C3 into two pieces. The small piece, C3a, floats off as an alarm signal. The large piece, C3b, is sticky — it bonds covalently to the microbe’s surface. And here is the beautiful part: deposited C3b helps build more convertase, which splits more C3, which deposits more C3b. That positive-feedback loop is the amplification you hear crackle in the animation, and it is why a single convertase can decorate a bacterium with a blizzard of tags in moments. It is also why an active cascade consumes C3 — watch the serum-C3 readout fall.
Opsonization: writing “eat me” on the enemy
A phagocyte — a neutrophil or macrophage — can be clumsy at grabbing a bare, slippery bacterium. Coat that bacterium in C3b and everything changes: phagocytes carry receptors (CR1, CR3) that lock onto C3b like handles. This coating-for-consumption is called opsonization, from a Greek word meaning “to prepare food.” The C3b tag is, quite literally, an “eat me” label. For many bacteria this is complement’s single most important contribution — not blowing the germ up, but flagging it so a hungry cell can find and swallow it. It is also why the drug scenario matters: even when the killing step is blocked, opsonization keeps working.
The Membrane Attack Complex: drilling the pore
If the cascade keeps rolling past C3 to C5, it turns lethal. C5 is split into C5a (another alarm) and C5b, and C5b nucleates the assembly of C6, C7, C8 and multiple copies of C9 into a ring that inserts straight through the target’s membrane. This ring is the Membrane Attack Complex (MAC), also written C5b-9. It is a physical pore: ions and water rush in, the bacterium can no longer hold its internal balance, and it swells and bursts — the pop you see and hear. The MAC is especially critical against one family of bacteria, Neisseria (which cause meningococcal meningitis and gonorrhea); people who can’t build the terminal complex get repeated, dangerous Neisseria infections.
C3a and C5a: the anaphylatoxins that call for backup
Those small fragments flung off at each cut — C3a and especially C5a — are not waste. They are anaphylatoxins: potent inflammatory signals. C5a is one of the strongest chemoattractants your body makes, laying down a scent trail that pulls neutrophils toward the infection, and it prods mast cells to release histamine, widening and loosening nearby blood vessels so more defenders can pour out of the bloodstream into the tissue. This is complement talking to the rest of the immune system: the fight is here — come now. It also explains why runaway complement drives so much damaging inflammation, from sepsis to certain kidney diseases.
Guarding your own cells — and what happens when the guard fails (PNH)
Here is the obvious danger: the alternative pathway sticks C3b to any surface. So why doesn’t it destroy you? Because your own cells wear regulator proteins that the pathogen lacks. CD55 (decay-accelerating factor) breaks apart any convertase that starts to form on a self surface, and CD59 (protectin) physically blocks the final C9 from completing the MAC. Together they are a password that says “friend.” In paroxysmal nocturnal haemoglobinuria (PNH), an acquired mutation in the PIGA gene stops blood cells from anchoring CD55 and CD59 to their surface. The password is gone, and complement — ticking over as always — steadily bursts the person’s own red blood cells. The freed haemoglobin spills into the urine, classically noticed as dark, cola-colored urine in the morning (the “nocturnal” in the name). Flip the PNH toggle in the Self-cell scenario to watch exactly this.
The drug that hits the off-switch: eculizumab
Because complement can turn on the body, medicine learned to throttle it. Eculizumab is a lab-made antibody that clamps onto C5 and stops it from being split — so no C5a and, crucially, no MAC. In PNH it dramatically reduces the destruction of red cells; it is also used in atypical haemolytic uraemic syndrome (aHUS), where uncontrolled complement injures the kidneys. The Eculizumab scenario shows the honest trade-off: the C3b opsonin tags still get written and phagocytes still clear germs, but the drilling stops. That trade-off has a real cost — blocking the terminal pathway is exactly the deficit that invites Neisseria, so people on these drugs must be vaccinated against meningococcus. (A longer-acting cousin, ravulizumab, works the same way with less frequent dosing.)
What a “low C3” on a blood test actually means
If a doctor orders a C3 (and often C4) level, they are usually not asking “is your immune system strong?” — they are asking “is complement being used up?” Because the cascade physically consumes these proteins as it fires, a low C3 often points to an active process chewing through it: certain kidney inflammations (some types of glomerulonephritis), active lupus flares, or serious infection. Which proteins drop can even hint at which pathway is engaged — a low C4 with low C3 suggests the classical or lectin pathway is involved, while a low C3 with a normal C4 points more to the alternative pathway. This is also why the animation lets you watch the C3 meter fall: seeing the number drop as the cascade runs is the whole intuition behind the test. (Reference ranges differ between labs, so always read your result against the range printed on your own report.)
The myth worth correcting
You’ll see supplements sold to “boost complement” as if more were always better. That misunderstands the system twice over. First, complement isn’t just a killing machine — a huge part of its daily job is quiet housekeeping: clearing dead cells, debris, and spent antibody complexes so they don’t inflame your tissues. People who are deficient in early classical-pathway proteins often don’t just get infections — they get autoimmune disease like lupus, because the garbage never gets collected. Second, complement that is over-active or poorly regulated is a driver of real illness — PNH, aHUS, some forms of kidney disease, and the inflammation of sepsis. The goal your body is always chasing is not “more” or “less” but balance: a cascade that fires hard on a germ and stays silent on you. No pill tunes that dial — the regulators in your own membranes do.